| abstract |
Provided is a salt of an HIV inhibitor compound. The present invention relates to salts of antiviral compounds, compositions comprising such salts, and therapeutic methods involving the administration of such salts, and processes and intermediates useful in the preparation of such salts. The present invention relates to ethyl N-[(S) ({[(2R, 5R) -5- (6-amino-9H-purin-9-yl) -4-fluoro-2,5-dihydrofuran-2-yl. ] Oxy} methyl) phenoxyphosphinoyl] -L-alaninate provides a stable salt of this compound that is physically more stable and easier to isolate and formulate. [Selection figure] None |